Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress

Qiagen NV has appointed Jonathan Pratt as its new chief executive officer, as talks with private equity firms about a possible sale of the European molecular testing company progress. The leadership change comes amid ongoing discussions that could reshape the company's ownership. Pratt's appointment signals a strategic move as Qiagen navigates potential acquisition scenarios with interested private equity buyers.